Evidence map›Paper›PMID 33544525›Full record

ArticleRadiology and oncology2021

TIPS

Spela Korsic, Borut Stabuc, Pavel Skok, Peter Popovic

Open access · goldAbstract read
In one paragraph

Article in Radiology and oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Spela KorsicClinical Institute of Radiology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Borut StabucFaculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Pavel SkokDepartment of Gastroenterology, University Medical Centre Maribor, Maribor, Slovenia.
Peter PopovicClinical Institute of Radiology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
University of Ljubljana · SILjubljana University Medical Centre · SIUniversity Clinical Centre Maribor · SI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecurrent bleeding from gastroesophageal varices is the most common life-threatening complication of portal hypertension. According to guidelines, transjugular intrahepatic portosystemic shunt (TIPS) should not be used as a first-line treatment and should be limited to those bleedings which are refractory to pharmacologic and endoscopic treatment (ET). To our knowledge, long-term studies evaluating the role of elective TIPS in comparison to ET in patients with recurrent variceal bleeding episodes are rare. PATIENTS AND

methodsThis study was designed as a retrospective single-institution analysis of 70 patients treated with TIPS and 56 with ET. Patients were followed-up from inclusion in the study until death, liver transplantation, the last follow-up observation or until the end of our study.

resultsRecurrent variceal bleeding was significantly more frequent in ET group compared to patients TIPS group (66.1%

conclusionsIn present study TIPS was more effective in the prevention of recurrent variceal bleeding and had lower mortality due to recurrent variceal bleeding compared to ET.

Indexed as

Cause of DeathEnbucrilateEndoscopyEsophageal and Gastric VaricesFemaleFollow-Up StudiesGastrointestinal HemorrhageHepatic EncephalopathyHumansHypertension, PortalLiver FailureMaleMiddle AgedPortasystemic Shunt, Transjugular IntrahepaticRecurrenceRetrospective StudiesEnbucrilateSclerosing Solutionsendoscopic treatmentesophageal and gastric varicesportal hypertensionrecurrent variceal bleedingsurvivaltransjugular intrahepatic portosystemic shunt

Identifiers

PMID33544525
PMCPMC8042829
OpenAlexW3128453778

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.